Effect of Different Dialysis Modalities on Microinflammatory Status and Endothelial Damage-Reference-Cited by-同舟云学术

Effect of Different Dialysis Modalities on Microinflammatory Status and Endothelial Damage

Published:2010-01-07 Issue:2 Volume:5 Page:227-234
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Merino Ana,Portolés José,Selgas Rafael,Ojeda Raquel,Buendia Paula,Ocaña Javier,Bajo M. Auxiliadora,del Peso Gloria,Carracedo Julia,Ramírez Rafael,Martín-Malo Alejandro,Aljama Pedro

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference38 articles.

1. Clinical Subtypes of Alzheimer’s Disease

2. Cardiovascular risk factors in chronic renal failure and hemodialysis populations;Ma;Am J Kidney Dis,1992

3. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis;Lameire;Kidney Int Suppl,1994

4. The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis

5. Carotid atherosclerosis is associated with inflammation, malnutrition and intercellular adhesion molecule-1 in patients on continuous ambulatory peritoneal dialysis

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunophenotypic Characterization of Citrate-Containing A Concentrates in Maintenance Hemodialysis: A Pre-Post Study;International Journal of Nephrology;2023-09-27

2. Dialysis Patients Respond Adequately to Influenza Vaccination Irrespective of Dialysis Modality and Chronic Inflammation;Journal of Clinical Medicine;2023-09-26

3. Proinflammatory role of monocytes in SARS-CoV-2 infection in chronic hemodialysis patients;Frontiers in Immunology;2023-08-03

4. Relation between Soluble CD14 Levels, Inflammation, Subclinical Atherosclerosis and Mortality in Hemodialysis Patients;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-05

5. Endothelial Extracellular Vesicles as Biomarkers of Toxic Molecules;Biomarkers in Toxicology;2023